Advancing Research with High-Quality Recombinant Proteins
Understanding Neuron-Related Factors: Essential Components of Neuronal Health and Function
Neuron-related factors are proteins that underpin neuronal development, survival, and function. It still surprises me how precisely these molecules shape neuronal fate. This group includes neurotrophic factors, cytokines, and growth factors, each with distinct roles in neuronal processes. Their study supports progress on neurological disorders and new therapeutic strategies, connecting receptor-level signaling such as MAPK and PI3K with applications in disease models, drug discovery, and regenerative approaches. We differentiate between these categories to provide a clear framework for their biological significance.
The Intricate Principles Governing Neuron-Related Factor Mechanisms of Action
Neuron-related factors act through defined cellular and molecular interactions. They bind to cell surface receptors and initiate intracellular signaling pathways, including MAPK and PI3K. These pathways govern neuronal differentiation, survival, axon guidance, and synaptic plasticity. The specificity of these interactions reflects the precision required in their study.
1. Neurotrophic Factor Signaling Pathways
Neurotrophic factors, such as NGF, BDNF, and GDNF, bind to high-affinity receptors on neuronal cell surfaces. This binding triggers a cascade of intracellular events that ultimately influences gene expression and protein synthesis. These pathways are foundational for neuronal development, maintenance, and repair, underscoring their profound impact on nervous system health.
Diverse Applications of Neuron-Related Factors in Research and Therapeutic Development
Neuron-related factors have broad applications across scientific and medical fields. They are indispensable in in vitro neuronal cell culture models for studying neuronal behavior and disease mechanisms. In drug discovery, these factors serve as targets or potential therapeutic agents for neurodegenerative conditions. They also hold promise in regenerative medicine and as diagnostic biomarkers. High-quality recombinant factors are critical for achieving reliable and reproducible research outcomes.
1. Neuron-Related Factors in Neurodegenerative Disease Research
Researchers investigate neuron-related factors as potential therapeutic agents for neurodegenerative diseases like Alzheimer’s, Parkinson’s, and ALS. These factors can offer protective effects against neuronal damage and promote neuronal regeneration. Understanding their roles is central to developing novel treatments.
If you are interested in exploring specific applications, we recommend reading 《Recombinant Human 4-1BBL: Unlocking Immune Co-stimulation for Advanced Therapies》 for insights into immune co-stimulation.
Emerging Trends and Future Directions in Neuron-Related Factor Research
The field of neuron-related factor research continues to evolve rapidly. Advancements include the development of gene therapies to deliver these factors directly to affected areas. Targeted delivery systems aim to enhance their efficacy and reduce off-target effects. Additionally, novel mimetics and antagonists are being designed to modulate their activity more precisely. High-quality recombinant proteins from suppliers like East-Mab are instrumental in facilitating these innovations.
High-Quality Recombinant Proteins for Research and Diagnostics
We provide a broad portfolio of recombinant proteins essential for advanced biological research and diagnostic development. Our products are manufactured under stringent quality control to ensure high purity and consistent performance.
| Product Name | Expression System | Molecular Weight | Purity | Endotoxin Level (EU/mg) | Bioactivity | Application/Notes |
|---|---|---|---|---|---|---|
| Recombinant Human IL-2 | CHO | 15.4 kDa | ≥95% | ≤1 | ≥1 x 10⁷ IU/mg | T-Cell Growth Factor for CTLL-2 cell proliferation assays |
| Recombinant Human IL-4 | CHO | 15 kDa | ≥95% | ≤10 | ED₅₀ ≤ 0.2 ng/mL | B-Cell Stimulatory Factor for TF-1 cell proliferation assays |
| Recombinant Human IL-6 | CHO | 20.8 kDa | ≥95% | ≤10 | ED₅₀ 0.2-1 ng/mL | Cytokine for M-NFS-60 cell proliferation assays |
| Recombinant Human IL-7 | CHO | 17.3 kDa | ≥95% | ≤10 | ED₅₀ ≤30 ng/mL | Cytokine for NALM-6 human pre-B cell proliferation assays |
| Recombinant Human FGF-2/bFGF | E. coli | 16.5 kDa | ≥95% | ≤20 | ED₅₀ ≤2.0 ng/mL | Fibroblast Growth Factor for NIH3T3 cell proliferation assays |
Contact Us
Explore how Jiangsu East-Mab Biomedical Technology Co., Ltd. provides high-quality recombinant protein raw materials, including a comprehensive range of neuron-related factors, to accelerate your research in neurobiology, cell culture, and diagnostic development. Contact us today to discuss your specific project needs and discover our world-class solutions.
Email: product@eastmab.com
Phone: +86-400-998-0106
FAQs
1. What are the primary functions of neurotrophic factors in the nervous system?
Neurotrophic factors support the survival, growth, differentiation, and maintenance of neurons. They play vital roles during neuronal development, preventing programmed cell death, promoting axon and dendrite outgrowth, and facilitating synaptic plasticity, which is necessary for learning and memory.
2. How are recombinant neuron-related factors produced for research and therapeutic applications?
Recombinant neuron-related factors are commonly produced using genetic engineering techniques where the gene encoding the factor is inserted into a host cell (e.g., E. coli, yeast, mammalian cells). These cells then express and produce large quantities of the desired protein, which is subsequently purified to high standards for research, diagnostic, or therapeutic use. Companies like East-Mab specialize in this high-quality production.
3. What are the challenges in utilizing neuron-related factors for treating neurodegenerative diseases?
Challenges include ensuring effective delivery across the blood-brain barrier, achieving sustained and localized therapeutic concentrations, potential off-target effects, and the stability and immunogenicity of the factors themselves. Research is ongoing to overcome these hurdles through advanced delivery systems and modified factor designs.